OBJECTIVE: To evaluate the cause of death and complications in a series of autopsied patients with rheumatoid arthritis (RA). METHODS: A clinicopathological study of 81 autopsied patients with RA was performed. RESULTS: In order of frequency, the causes of death were infection (23.5%), heart disease (17.3%), respiratory failure (9.9%), renal failure (9.9%), and gastrointestinal disease (9.9%). Observed complications of RA were systemic angiitis in 25 cases (30.8%), systemic amyloidosis in 17 cases (21.0%), and pulmonary fibrosis in 28 cases (34.6%). No patient had both angiitis and amyloidosis simultaneously. The prevalence of systemic angiitis tended to decrease during the study period (1960-1990), while systemic amyloidosis tended to increase. CONCLUSION: The cause of death in RA is difficult to analyze accurately because RA itself is a chronic systemic inflammation disease.
OBJECTIVE: To evaluate the cause of death and complications in a series of autopsied patients with rheumatoid arthritis (RA). METHODS: A clinicopathological study of 81 autopsied patients with RA was performed. RESULTS: In order of frequency, the causes of death were infection (23.5%), heart disease (17.3%), respiratory failure (9.9%), renal failure (9.9%), and gastrointestinal disease (9.9%). Observed complications of RA were systemic angiitis in 25 cases (30.8%), systemic amyloidosis in 17 cases (21.0%), and pulmonary fibrosis in 28 cases (34.6%). No patient had both angiitis and amyloidosis simultaneously. The prevalence of systemic angiitis tended to decrease during the study period (1960-1990), while systemic amyloidosis tended to increase. CONCLUSION: The cause of death in RA is difficult to analyze accurately because RA itself is a chronic systemic inflammation disease.
Authors: Jorge A Zamora-Legoff; Megan L Krause; Cynthia S Crowson; Jay H Ryu; Eric L Matteson Journal: Rheumatology (Oxford) Date: 2017-03-01 Impact factor: 7.580
Authors: José Félix Restrepo; Inmaculada del Rincón; Daniel F Battafarano; Roy W Haas; Merced Doria; Agustín Escalante Journal: Clin Rheumatol Date: 2015-08-09 Impact factor: 2.980